Stephanie Wang enjoyed speaking on the Women's Health: Digital Health and Beyond panel at NewYorkBIO's Finance Summit! Seth Flaum Kirthika Parmeswaran Lauren Weiniger #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
About us
FemHealth Ventures invests in groundbreaking innovators in women’s health, focusing on drugs, devices, diagnostics, and digital applications. We are the first to (re)imagine women’s health to include conditions that affect only women, affect mostly women, or appear differently in women.
- Website
-
http://www.femhealthventures.com
External link for FemHealth Ventures
- Industry
- Investment Management
- Company size
- 2-10 employees
- Headquarters
- NY Metropolitan Area
- Type
- Privately Held
- Specialties
- Women's health and Venture capital
Locations
-
Primary
Get directions
NY Metropolitan Area, US
Employees at FemHealth Ventures
Updates
-
Maneesha Ghiya enjoyed speaking at the AHIP 2024 Conference in Las Vegas! #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
-
-
The FDA has approved its first closed-loop, insulin pump-controlling smartphone app that can cover pregnant women with Type 1 diabetes, CamDiab. #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
-
Sara Crown Star enjoyed participating as a judge at University of Chicago Booth's New Venture Challenge! #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
-
-
Labcorp has launched a new blood test for the risk assessment of preeclampsia, with results as early as the first trimester. #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
Labcorp unveils first-trimester blood test for detecting preeclampsia risks
fiercebiotech.com
-
Our Venture Partner, Sara Crown Star, is excited to speak at the Toronto Family Office Conference on May 28th! #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
-
-
A recent article by The Wall Street Journal reveals ways in which the brain changes during pregnancy. #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
Pregnancy Shrinks Your Brain. But It Strengthens It Too.
wsj.com
-
FemHealth Ventures participated in a $103M Series A financing round for Reunion Neuroscience. Reunion Neuroscience's lead asset is a fast-acting antidepressant for patients suffering from postpartum depression. #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Greg Mayes Mark Theeuwes Nathan Bryson, PhD Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
MPM BioImpact-owned Reunion raises $103M, one of the largest rounds for a psychedelic biotech
fiercebiotech.com
-
Maneesha Ghiya enjoyed speaking on The Future of Women's Health panel at the Trustees' Council of Penn Women's 2024 Spring Conference. #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures hildegard toth Carmen Alvarez, PhD, CRNP, CNM Aliya Karmally Sahai Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
-
-
FemHealth Ventures’ portfolio company, Raydiant Oximetry, has received FDA approval for its investigational device exemption (IDE) study of Lumerah™ in an Early Feasibility Study (EFS) of pregnant women during labor and delivery. #Healthcare #Womenshealth #Womenshealthcare #Healthcareinnovation #Venturecapital #VC #Impactinvesting #Femtech #Femhealth #FemHealthVentures Maneesha Ghiya Susanne Seripiero Sara Crown Star Sean Ainsworth Greg Brown Dr. Nisha Chakravarty Randolph Cohen Katherine Bach Kalin Stephan Oppenheimer Rache Simmons MD MS MBA Stephanie Wang
Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study
globenewswire.com